rs56737058

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_003383.5(VLDLR):​c.2291C>T​(p.Thr764Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000737 in 1,613,896 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T764T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0025 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 1 hom. )

Consequence

VLDLR
NM_003383.5 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.06

Publications

4 publications found
Variant links:
Genes affected
VLDLR (HGNC:12698): (very low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene. [provided by RefSeq, Aug 2009]
VLDLR Gene-Disease associations (from GenCC):
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • cerebellar ataxia, intellectual disability, and dysequilibrium
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003383.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007685244).
BP6
Variant 9-2651454-C-T is Benign according to our data. Variant chr9-2651454-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130708.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00246 (374/152222) while in subpopulation AFR AF = 0.00713 (296/41540). AF 95% confidence interval is 0.00646. There are 0 homozygotes in GnomAd4. There are 170 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003383.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VLDLR
NM_003383.5
MANE Select
c.2291C>Tp.Thr764Met
missense
Exon 16 of 19NP_003374.3
VLDLR
NM_001322225.2
c.2168C>Tp.Thr723Met
missense
Exon 15 of 18NP_001309154.1A0A7P0T897
VLDLR
NM_001018056.3
c.2252-420C>T
intron
N/ANP_001018066.1P98155-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VLDLR
ENST00000382100.8
TSL:1 MANE Select
c.2291C>Tp.Thr764Met
missense
Exon 16 of 19ENSP00000371532.2P98155-1
VLDLR
ENST00000382099.3
TSL:1
c.1847C>Tp.Thr616Met
missense
Exon 12 of 15ENSP00000371531.3A0A804CHQ2
VLDLR
ENST00000947327.1
c.2288C>Tp.Thr763Met
missense
Exon 16 of 19ENSP00000617386.1

Frequencies

GnomAD3 genomes
AF:
0.00246
AC:
374
AN:
152104
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00715
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00269
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00120
AC:
302
AN:
250652
AF XY:
0.00103
show subpopulations
Gnomad AFR exome
AF:
0.00900
Gnomad AMR exome
AF:
0.00226
Gnomad ASJ exome
AF:
0.00219
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000415
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.000558
AC:
816
AN:
1461674
Hom.:
1
Cov.:
31
AF XY:
0.000503
AC XY:
366
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.00830
AC:
278
AN:
33474
American (AMR)
AF:
0.00217
AC:
97
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00172
AC:
45
AN:
26132
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39688
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86242
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.000278
AC:
309
AN:
1111918
Other (OTH)
AF:
0.00121
AC:
73
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00246
AC:
374
AN:
152222
Hom.:
0
Cov.:
33
AF XY:
0.00228
AC XY:
170
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00713
AC:
296
AN:
41540
American (AMR)
AF:
0.00268
AC:
41
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68002
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00114
Hom.:
2
Bravo
AF:
0.00308
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000818
EpiControl
AF:
0.000593

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 (2)
-
-
1
not specified (1)
-
-
1
VLDLR-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.075
Eigen_PC
Benign
-0.022
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.73
T
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.0077
T
MetaSVM
Benign
-0.41
T
MutationAssessor
Benign
1.4
L
PhyloP100
1.1
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.26
Sift
Benign
0.051
T
Sift4G
Benign
0.12
T
Varity_R
0.030
gMVP
0.49
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs56737058;
hg19: chr9-2651454;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.